Skip to main content
Top
Published in: Surgery Today 9/2015

01-09-2015 | Original Article

Surgical outcomes of pulmonary metastases from esophageal carcinoma diagnosed by both pathological and clinical criteria

Authors: Yoshiki Kozu, Shiaki Oh, Kazuya Takamochi, Kenji Suzuki

Published in: Surgery Today | Issue 9/2015

Login to get access

Abstract

Purpose

This investigation was performed to examine the surgical outcomes of pulmonary metastases from esophageal carcinoma (EC) diagnosed by both pathological and clinical criteria.

Methods

Based on the pathological criteria, we identified 22 patients who had undergone pulmonary metastasectomy for EC between 1997 and 2011. Thehistological type of EC was squamous cell carcinoma (SCC) in all patients. After specific clinical criteria were applied, seven patients suspected of having primary lung SCC were excluded. The surgical outcomes of the remaining 15 patients were reviewed. The overall survival (OS) was calculated as the period from pulmonary resection until death or the date of the last follow-up.

Results

The 1-, 3- and 4-year OS rates of the 15 patients were 93, 44 and 0 % respectively, with a median OS of 32 months. A larger diameter of the pulmonary metastasis was marginally associated with a poorer OS (p = 0.087); however, none of the parameters were significant prognostic factors.

Conclusions

The median OS of patients who underwent surgical resection for pulmonary metastases from EC was comparable to that in previous reports, even after excluding patients clinically suspected of having a second primary lung SCC. The poor long-term survival might indicate that our clinical criteria are helpful in selecting true metastatic patients, considering the aggressive clinical course of metastatic EC.
Literature
1.
go back to reference Kozu Y, Sato H, Tsubosa Y, Ogawa H, Yasui H, Kondo H. Surgical treatment for pulmonary metastases from esophageal carcinoma after definitive chemoradiotherapy: experience from a single institution. J Cardiothorac Surg. 2011. doi:10.1186/1749-8090-6-135.PubMedCentralPubMed Kozu Y, Sato H, Tsubosa Y, Ogawa H, Yasui H, Kondo H. Surgical treatment for pulmonary metastases from esophageal carcinoma after definitive chemoradiotherapy: experience from a single institution. J Cardiothorac Surg. 2011. doi:10.​1186/​1749-8090-6-135.PubMedCentralPubMed
2.
go back to reference Chen F, Sato K, Sakai H, Miyahara R, Bando T, Okubo K, et al. Pulmonary resection for metastasis from esophageal carcinoma. Interact CardioVasc Thorac Surg. 2008;7:809–12.CrossRefPubMed Chen F, Sato K, Sakai H, Miyahara R, Bando T, Okubo K, et al. Pulmonary resection for metastasis from esophageal carcinoma. Interact CardioVasc Thorac Surg. 2008;7:809–12.CrossRefPubMed
3.
go back to reference Ichikawa H, Kosugi S, Nakagawa S, Kanda T, Tsuchida M, Koike T, et al. Operative treatment for metachronous pulmonary metastasis from esophageal carcinoma. Surgery. 2011;149:164–70.CrossRefPubMed Ichikawa H, Kosugi S, Nakagawa S, Kanda T, Tsuchida M, Koike T, et al. Operative treatment for metachronous pulmonary metastasis from esophageal carcinoma. Surgery. 2011;149:164–70.CrossRefPubMed
5.
go back to reference Shiono S, Kawamura M, Sato T, Nakagawa K, Nakajima J, Yoshino I, et al. Disease-free interval length correlates to prognosis of patients who underwent metastasectomy for esophageal lung metastases. J Thorac Oncol. 2008;3:1046–9.CrossRefPubMed Shiono S, Kawamura M, Sato T, Nakagawa K, Nakajima J, Yoshino I, et al. Disease-free interval length correlates to prognosis of patients who underwent metastasectomy for esophageal lung metastases. J Thorac Oncol. 2008;3:1046–9.CrossRefPubMed
6.
go back to reference Geurts TW, Nederlof PM, van den Brekel MW, van’t Veer LJ, de Jong D, Hart AA, et al. Pulmonary squamous cell carcinoma following head and neck squamous cell carcinoma: metastasis or second primary? Clin Cancer Res. 2005;11:6608–14.CrossRefPubMed Geurts TW, Nederlof PM, van den Brekel MW, van’t Veer LJ, de Jong D, Hart AA, et al. Pulmonary squamous cell carcinoma following head and neck squamous cell carcinoma: metastasis or second primary? Clin Cancer Res. 2005;11:6608–14.CrossRefPubMed
7.
go back to reference Hirosawa T, Itabashi M, Ohnuki T, Yamaguchi N, Sugihara K, Kameoka S. Prognostic factors in patients undergoing complete resection of pulmonary metastases of colorectal cancer: a multi-institutional cumulative follow-up study. Surg Today. 2013;43:494–9.CrossRefPubMed Hirosawa T, Itabashi M, Ohnuki T, Yamaguchi N, Sugihara K, Kameoka S. Prognostic factors in patients undergoing complete resection of pulmonary metastases of colorectal cancer: a multi-institutional cumulative follow-up study. Surg Today. 2013;43:494–9.CrossRefPubMed
8.
go back to reference Kobayashi Y, Fukui T, Ito S, Shitara K, Hatooka S, Mitsudomi T. Pulmonary metastasectomy for gastric cancer: a 13-year single-institution experience. Surg Today. 2013;43:1382–9.CrossRefPubMed Kobayashi Y, Fukui T, Ito S, Shitara K, Hatooka S, Mitsudomi T. Pulmonary metastasectomy for gastric cancer: a 13-year single-institution experience. Surg Today. 2013;43:1382–9.CrossRefPubMed
9.
go back to reference Matsui T, Kitamura T, Ozawa H, Matsuguma H, Kotake K. Analysis of treatment that includes both hepatic and pulmonary resections for colorectal metastases. Surg Today. 2014;44:702–11.CrossRefPubMed Matsui T, Kitamura T, Ozawa H, Matsuguma H, Kotake K. Analysis of treatment that includes both hepatic and pulmonary resections for colorectal metastases. Surg Today. 2014;44:702–11.CrossRefPubMed
10.
go back to reference Ohba T, Yano T, Yoshida T, Kawano D, Tsukamoto S, Shoji F, et al. Results of a surgical resection of pulmonary metastasis from hepatocellular carcinoma: prognostic impact of the preoperative serum alpha-fetoprotein level. Surg Today. 2012;42:526–31.CrossRefPubMed Ohba T, Yano T, Yoshida T, Kawano D, Tsukamoto S, Shoji F, et al. Results of a surgical resection of pulmonary metastasis from hepatocellular carcinoma: prognostic impact of the preoperative serum alpha-fetoprotein level. Surg Today. 2012;42:526–31.CrossRefPubMed
11.
go back to reference Leong PP, Rezai B, Koch WM, Reed A, Eisele D, Lee DJ, et al. Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma. J Natl Cancer Inst. 1998;90:972–7.CrossRefPubMed Leong PP, Rezai B, Koch WM, Reed A, Eisele D, Lee DJ, et al. Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma. J Natl Cancer Inst. 1998;90:972–7.CrossRefPubMed
12.
go back to reference Hong WK, Lippman SM, Itri LM, Karp DD, Lee JS, Byers RM, et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med. 1990;323:795–801.CrossRefPubMed Hong WK, Lippman SM, Itri LM, Karp DD, Lee JS, Byers RM, et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med. 1990;323:795–801.CrossRefPubMed
13.
go back to reference Chung KY, Mukhopadhyay T, Kim J, Casson A, Ro JY, Goepfert H, et al. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Cancer Res. 1993;53:1676–83.PubMed Chung KY, Mukhopadhyay T, Kim J, Casson A, Ro JY, Goepfert H, et al. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Cancer Res. 1993;53:1676–83.PubMed
14.
go back to reference Finley RK 3rd, Verazin GT, Driscoll DL, Blumenson LE, Takita H, Bakamjian V, et al. Results of surgical resection of pulmonary metastases of squamous cell carcinoma of the head and neck. Am J Surg. 1992;164:594–8.CrossRefPubMed Finley RK 3rd, Verazin GT, Driscoll DL, Blumenson LE, Takita H, Bakamjian V, et al. Results of surgical resection of pulmonary metastases of squamous cell carcinoma of the head and neck. Am J Surg. 1992;164:594–8.CrossRefPubMed
15.
go back to reference Schwartz LH, Ozsahin M, Zhang GN, Touboul E, De Vataire F, Andolenko P, et al. Synchronous and metachronous head and neck carcinomas. Cancer. 1994;74:1933–8.CrossRefPubMed Schwartz LH, Ozsahin M, Zhang GN, Touboul E, De Vataire F, Andolenko P, et al. Synchronous and metachronous head and neck carcinomas. Cancer. 1994;74:1933–8.CrossRefPubMed
16.
go back to reference Jones AS, Morar P, Phillips DE, Field JK, Husband D, Helliwell TR. Second primary tumors in patients with head and neck squamous cell carcinoma. Cancer. 1995;75:1343–53.CrossRefPubMed Jones AS, Morar P, Phillips DE, Field JK, Husband D, Helliwell TR. Second primary tumors in patients with head and neck squamous cell carcinoma. Cancer. 1995;75:1343–53.CrossRefPubMed
17.
go back to reference Mariette C, Balon JM, Piessen G, Fabre S, Van Seuningen I, Triboulet JP. Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease. Cancer. 2003;97:1616–23.CrossRefPubMed Mariette C, Balon JM, Piessen G, Fabre S, Van Seuningen I, Triboulet JP. Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease. Cancer. 2003;97:1616–23.CrossRefPubMed
18.
go back to reference Abate E, DeMeester SR, Zehetner J, Oezcelik A, Ayazi S, Costales J, et al. Recurrence after esophagectomy for adenocarcinoma: defining optimal follow-up intervals and testing. J Am Coll Surg. 2010;210:428–35.CrossRefPubMed Abate E, DeMeester SR, Zehetner J, Oezcelik A, Ayazi S, Costales J, et al. Recurrence after esophagectomy for adenocarcinoma: defining optimal follow-up intervals and testing. J Am Coll Surg. 2010;210:428–35.CrossRefPubMed
19.
go back to reference Lou F, Sima CS, Adusumilli PS, Bains MS, Sarkaria IS, Rusch VW, et al. Esophageal cancer recurrence patterns and implications for surveillance. J Thorac Oncol. 2013;8:1558–62.PubMedCentralCrossRefPubMed Lou F, Sima CS, Adusumilli PS, Bains MS, Sarkaria IS, Rusch VW, et al. Esophageal cancer recurrence patterns and implications for surveillance. J Thorac Oncol. 2013;8:1558–62.PubMedCentralCrossRefPubMed
20.
go back to reference Jiao X, Krasna MJ. Clinical significance of micrometastasis in lung and esophageal cancer: a new paradigm in thoracic oncology. Ann Thorac Surg. 2002;74:278–84.CrossRefPubMed Jiao X, Krasna MJ. Clinical significance of micrometastasis in lung and esophageal cancer: a new paradigm in thoracic oncology. Ann Thorac Surg. 2002;74:278–84.CrossRefPubMed
21.
go back to reference Pfannschmidt J, Muley T, Hoffmann H, Dienemann H. Prognostic factors and survival after complete resection of pulmonary metastases from colorectal carcinoma: experiences in 167 patients. J Thorac Cardiovasc Surg. 2003;126:732–9.CrossRefPubMed Pfannschmidt J, Muley T, Hoffmann H, Dienemann H. Prognostic factors and survival after complete resection of pulmonary metastases from colorectal carcinoma: experiences in 167 patients. J Thorac Cardiovasc Surg. 2003;126:732–9.CrossRefPubMed
22.
go back to reference Saito Y, Omiya H, Kohno K, Kobayashi T, Itoi K, Teramachi M, et al. Pulmonary metastasectomy for 165 patients with colorectal carcinoma: a prognostic assessment. J Thorac Cardiovasc Surg. 2002;124:1007–13.CrossRefPubMed Saito Y, Omiya H, Kohno K, Kobayashi T, Itoi K, Teramachi M, et al. Pulmonary metastasectomy for 165 patients with colorectal carcinoma: a prognostic assessment. J Thorac Cardiovasc Surg. 2002;124:1007–13.CrossRefPubMed
Metadata
Title
Surgical outcomes of pulmonary metastases from esophageal carcinoma diagnosed by both pathological and clinical criteria
Authors
Yoshiki Kozu
Shiaki Oh
Kazuya Takamochi
Kenji Suzuki
Publication date
01-09-2015
Publisher
Springer Japan
Published in
Surgery Today / Issue 9/2015
Print ISSN: 0941-1291
Electronic ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-014-1036-8

Other articles of this Issue 9/2015

Surgery Today 9/2015 Go to the issue